Breaking the Chain of Cardiovascular Disease: Strategies for Reducing Risk Across the Cardiovascular Continuum

From a Vulnerable Plaque to a Vulnerable Patient

The Invisible Patient: A Case-Based Approach to Treating Dyslipidemia

Women and Heart Disease: Matching Intensity of Risk to Intensity of Prevention

Global Preventive Strategies: Minimizing Risk Across the Cardiovascular Continuum

Understanding the Pleiotropic Effects of Lipid-Lowering Therapies/Review of Key 2005 Clinical Trials

Inflammation, hsCRP, and Statin Therapy: Clinical Implications for Prevention and Treatment /New Ideologies: Plaque Stabilization and Regression

Managing Dyslipidemia in Patients with Diabetes/Nonpharmacologic Interventions for Treatment of Dyslipidemia

Cardiovascular Risk: The Impact of Established Factors and Emerging Markers/Improving Adherence with Lipid Therapies

Safety Considerations for Combination Therapy/Highlights from the 2005 AHA Scientific Sessions

Transforming the Paradigm for the Metabolic Syndrome/Highlights from the 2005 EASD Annual Meeting